Briefing: Milk-derived nanoparticles may enable physicians to target aggressive bile duct cancer

Strategic angle: Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors using milk-derived nanoparticles.